endometriosis - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

RGD DISEASE ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:	endometriosis	go back to main search page
Accession:	DOID:289	browse the term
Definition:	A female reproductive system disease characterized by the growth of endometrial tissue outside the uterine body. (DO)
Synonyms:	exact_synonym:	ENDO1; endometrioma; endometriomas; endometrioses
	related_synonym:	ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1
	primary_id:	MESH:D004715
	alt_id:	MIM:131200
	xref:	EFO:0001065; ICD10CM:N80; ICD10CM:N80.9; ICD9CM:617; NCI:C3014
For additional species annotation, visit the Alliance of Genome Resources.

show annotations for term's descendants Sort by:
Rat (392) Mouse (382) Human (3946) Chinchilla (353) Bonobo (377) Dog (372) Squirrel (364) Pig (369) Green Monkey (372) Naked Mole-rat (355) All
Genes (382)

endometriosis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP-binding cassette, sub-family C member 4

CTD Direct Evidence: marker/mechanism

NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631

G

ATP-binding cassette, sub-family C member 9

CTD Direct Evidence: marker/mechanism

NCBI chr 6:142,533,592...142,648,472
Ensembl chr 6:142,533,588...142,648,041

G

ABI family member 3 binding protein

CTD Direct Evidence: marker/mechanism

NCBI chr16:56,298,179...56,510,498
Ensembl chr16:56,298,241...56,510,498

G

actin alpha 2, smooth muscle, aorta

CTD Direct Evidence: marker/mechanism

NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990

G

aldo-keto reductase family 1 member B

CTD Direct Evidence: marker/mechanism

NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413

G

aldo-keto reductase family 1, member C18

CTD Direct Evidence: marker/mechanism

PMID:21232532 PMID:25446850

NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653

G

aldo-keto reductase family 1, member C21

CTD Direct Evidence: marker/mechanism

NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540

G

angiogenin, ribonuclease, RNase A family, 5

RGD

PMID:14748845 PMID:15236995

RGD:2325705, RGD:6892724

NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466

G

progressive ankylosis

CTD Direct Evidence: marker/mechanism

NCBI chr15:27,466,763...27,594,995
Ensembl chr15:27,466,763...27,594,995

G

ankyrin repeat domain 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:36,089,365...36,097,244
Ensembl chr19:36,089,361...36,097,499

G

anoctamin 4

CTD Direct Evidence: marker/mechanism

NCBI chr10:88,784,794...89,181,059
Ensembl chr10:88,784,856...89,180,624

G

androgen receptor

no_association

RGD

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

amphiregulin

CTD Direct Evidence: marker/mechanism

NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291

G

Rho GTPase activating protein 28

CTD Direct Evidence: marker/mechanism

NCBI chr17:68,149,701...68,311,185
Ensembl chr17:68,149,708...68,311,115

G

aryl hydrocarbon receptor nuclear translocator

CTD Direct Evidence: marker/mechanism

NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551

G

BCL2-associated X protein

treatment

RGD

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

B cell leukemia/lymphoma 2

treatment

protein:increased expression:endometrium

RGD

PMID:17693084 PMID:25937801 PMID:23406865

RGD:2293018, RGD:11353846, RGD:7257718

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

BCL2-like 1

treatment

RGD

NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648

G

baculoviral IAP repeat-containing 5

RGD

NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569

G

bone morphogenetic protein 7

CTD Direct Evidence: marker/mechanism

NCBI chr 2:172,709,805...172,782,114
Ensembl chr 2:172,709,805...172,782,114

G

bromodomain containing 8

CTD Direct Evidence: marker/mechanism

NCBI chr18:34,731,668...34,757,916
Ensembl chr18:34,731,668...34,757,654

G

complement component 1, r subcomponent B

CTD Direct Evidence: marker/mechanism

NCBI chr 6:124,547,389...124,558,003
Ensembl chr 6:124,547,253...124,558,130

G

C-C motif chemokine ligand 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:82,067,492...82,070,638
Ensembl chr11:82,067,483...82,196,516

G

C-C motif chemokine ligand 11

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:30579999 PMID:18595729

NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781

G

C-C motif chemokine ligand 2

protein:increased expression:peritoneal fluid (human)

RGD

NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279

G

C-C motif chemokine ligand 22

CTD Direct Evidence: marker/mechanism

NCBI chr 8:95,472,312...95,478,016
Ensembl chr 8:95,472,218...95,478,327

G

C-C motif chemokine ligand 5

mRNA:increased expression:endometrium (human)

RGD

NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344

G

cyclin E2

CTD Direct Evidence: marker/mechanism

NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779

G

CD226 antigen

CTD Direct Evidence: marker/mechanism

NCBI chr18:89,195,078...89,290,356
Ensembl chr18:89,195,091...89,290,353

G

CD36 molecule

mRNA, protein:decreased expression:macrophage

RGD

NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799

G

CD55 molecule, decay accelerating factor for complement

CTD Direct Evidence: marker/mechanism

NCBI chr 1:130,357,526...130,390,513
Ensembl chr 1:130,366,764...130,390,481

G

complement factor D

CTD Direct Evidence: marker/mechanism

NCBI chr10:79,726,687...79,728,489
Ensembl chr10:79,726,687...79,728,489

G

claudin 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591

G

cornichon family AMPA receptor auxiliary protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:181,178,024...181,288,059
Ensembl chr 1:181,180,193...181,288,206

G

cannabinoid receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831

G

COP9 signalosome subunit 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:125,672,222...125,701,002
Ensembl chr 2:125,672,224...125,701,059

G

carboxypeptidase M

CTD Direct Evidence: marker/mechanism

NCBI chr10:117,465,405...117,523,257
Ensembl chr10:117,465,405...117,523,257

G

colony stimulating factor 1 (macrophage)

protein:increased expression:peritoneal fluid (human)

RGD

NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785

G

catenin beta 1

protein:increased expression:endometrium, epithelium, stroma (human)

RGD

NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573

G

C-X-C motif chemokine ligand 13

CTD Direct Evidence: marker/mechanism

NCBI chr 5:96,104,785...96,108,927
Ensembl chr 5:96,104,810...96,108,927

G

C-X-C motif chemokine ligand 14

CTD Direct Evidence: marker/mechanism

NCBI chr13:56,436,456...56,444,624
Ensembl chr13:56,436,456...56,444,364

G

C-X-C motif chemokine ligand 15

protein:increased expression:peritoneal fluid (human)

RGD

PMID:29962266 PMID:25704572

RGD:150520017, RGD:150521547

NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926

G

C-X-C motif chemokine ligand 9

CTD Direct Evidence: marker/mechanism

NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938

G

cytochrome b5 type A (microsomal)

CTD Direct Evidence: marker/mechanism

NCBI chr18:84,869,463...84,897,996
Ensembl chr18:84,856,829...84,897,996

G

cytochrome P450, family 19, subfamily a, polypeptide 1

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:18815356 PMID:21958689 PMID:8550748 PMID:23406865

RGD:7257715, RGD:7257718

NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394

G

cytochrome P450, family 1, subfamily a, polypeptide 1

RGD

NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107

G

cytochrome P450, family 26, subfamily a, polypeptide 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:37,686,186...37,689,984
Ensembl chr19:37,686,246...37,689,984

G

dendrocyte expressed seven transmembrane protein

CTD Direct Evidence: marker/mechanism

NCBI chr15:39,609,326...39,624,334
Ensembl chr15:39,609,326...39,624,334

G

DEAD box helicase 5

CTD Direct Evidence: marker/mechanism

NCBI chr11:106,671,181...106,680,011
Ensembl chr11:106,671,181...106,680,011

G

DEPP1 autophagy regulator

CTD Direct Evidence: marker/mechanism

NCBI chr 6:116,627,645...116,629,808
Ensembl chr 6:116,627,570...116,629,755

G

dicer 1, ribonuclease type III

CTD Direct Evidence: marker/mechanism

NCBI chr12:104,654,001...104,718,331
Ensembl chr12:104,654,001...104,718,211

G

deiodinase, iodothyronine, type II

CTD Direct Evidence: marker/mechanism

NCBI chr12:90,691,326...90,705,812
Ensembl chr12:90,691,326...90,705,812

G

dickkopf WNT signaling pathway inhibitor 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:30,523,276...30,526,896
Ensembl chr19:30,523,263...30,527,065

G

DNA methyltransferase 1

mRNA,protein:decreased expression:endometrium:

RGD

NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184

G

DNA methyltransferase 3A

mRNA:increased expression:endometrium:

RGD

NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443

G

DNA methyltransferase 3B

mRNA:increased expression:endometrium:

RGD

NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650

G

dual specificity phosphatase 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102

G

estrogen receptor-binding fragment-associated gene 9

protein:decreased expression:endometrium

RGD

NCBI chr15:44,482,574...44,504,916
Ensembl chr15:44,482,571...44,504,911

G

epidermal growth factor receptor

CTD Direct Evidence: marker/mechanism

NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158

G

early growth response 1

mRNA, protein:increased expression:ovary

RGD

NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037

G

ELAV like RNA binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:4,334,781...4,375,104
Ensembl chr 8:4,335,382...4,375,413

G

ectonucleotide pyrophosphatase/phosphodiesterase 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:24,513,812...24,588,057
Ensembl chr10:24,513,812...24,588,057

G

ERBB receptor feedback inhibitor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:150,938,253...150,953,346
Ensembl chr 4:150,938,376...150,953,349

G

estrogen receptor 1 (alpha)

RGD

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

estrogen receptor 2 (beta)

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17625110 PMID:15618247

NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033

G

enhancer of zeste 2 polycomb repressive complex 2 subunit

treatment

RGD

NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275

G

family with sequence similarity 180, member A

CTD Direct Evidence: marker/mechanism

NCBI chr 6:35,289,678...35,303,076
Ensembl chr 6:35,289,603...35,303,076

G

fibulin 1

CTD Direct Evidence: marker/mechanism

NCBI chr15:85,090,150...85,170,495
Ensembl chr15:85,090,150...85,170,736

G

fibrillin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:125,142,514...125,348,417
Ensembl chr 2:125,142,514...125,349,913

G

fibroblast growth factor receptor 2

no_association

DNA:SNPs
mRNA:increased expression:ovary, epithelial cell

RGD

PMID:18285324 PMID:17482184

RGD:2301190, RGD:2301191

NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079

G

FK506 binding protein 5

CTD Direct Evidence: marker/mechanism

NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501

G

flavin containing monooxygenase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:162,701,886...162,726,327
Ensembl chr 1:162,701,886...162,726,295

G

FBJ osteosarcoma oncogene

CTD Direct Evidence: marker/mechanism

NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047

G

forkhead box P3

severity

RGD

NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484

G

vitamin D binding protein

severity

RGD

NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757

G

growth hormone releasing hormone

mRNA:decreased expression:ovary

RGD

NCBI chr 2:157,171,416...157,190,645
Ensembl chr 2:157,171,417...157,189,426

G

G protein-coupled estrogen receptor 1

protein:decreased expression:endometrium (mouse)
protein:increased expression:endometrium, cytoplasm (human)

RGD

PMID:32152908 PMID:22520060

RGD:39938861, RGD:39939083

NCBI chr 5:139,408,905...139,413,555
Ensembl chr 5:139,408,906...139,413,555

G

glutathione peroxidase 3

CTD Direct Evidence: marker/mechanism

PMID:20864642 PMID:21063030

NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203

G

gene regulated by estrogen in breast cancer protein

CTD Direct Evidence: marker/mechanism

NCBI chr12:16,720,616...16,851,395
Ensembl chr12:16,720,616...16,850,887

G

histocompatibility 2, class II antigen E beta

severity

DNA:SNP: :rs660895 (human)

RGD

NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648

G

heparin-binding EGF-like growth factor

CTD Direct Evidence: marker/mechanism

NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858

G

histone deacetylase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506

G

histone deacetylase 2

treatment

protein:decreased expression:ectopic endometrium, dorsal root ganglion:
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:22138541 PMID:20884991

NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885

G

histone deacetylase 3

OMIM:131200

NCBI chr18:38,070,024...38,088,073
Ensembl chr18:38,068,897...38,088,069

G

heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1

CTD Direct Evidence: marker/mechanism

NCBI chr11:63,775,519...63,813,110
Ensembl chr11:63,776,618...63,813,116

G

hydroxysteroid (17-beta) dehydrogenase 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:100,968,792...100,972,014
Ensembl chr11:100,969,237...100,971,353

G

hydroxysteroid (17-beta) dehydrogenase 2

CTD Direct Evidence: marker/mechanism

PMID:18815356 PMID:21232532

NCBI chr 8:118,427,752...118,485,767
Ensembl chr 8:118,428,643...118,485,766

G

indoleamine 2,3-dioxygenase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025

G

interferon induced protein with tetratricpeptide repeats 1B like 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:34,570,288...34,640,382
Ensembl chr19:34,570,291...34,579,356

G

interferon gamma

mRNA:increased expression:colon

RGD

NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797

G

interferon gamma receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:19,467,697...19,485,977
Ensembl chr10:19,467,697...19,485,977

G

insulin-like growth factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904

G

insulin-like growth factor binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546

G

insulin-like growth factor binding protein 6

CTD Direct Evidence: marker/mechanism

NCBI chr15:102,052,621...102,057,947
Ensembl chr15:102,052,797...102,057,946

G

Indian hedgehog

CTD Direct Evidence: marker/mechanism

NCBI chr 1:74,984,474...74,990,831
Ensembl chr 1:74,984,474...74,990,831

G

interleukin 10

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:30579999 PMID:21665488

NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711

G

interleukin 15

CTD Direct Evidence: marker/mechanism

NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851

G

interleukin 1 beta

ClinVar Annotator: match by term: Endometriosis

NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059

G

interleukin 1 family, member 10

ClinVar Annotator: match by term: Endometriosis

NCBI chr 2:24,177,095...24,184,236
Ensembl chr 2:24,181,208...24,183,832

G

interleukin 1 receptor, type I

CTD Direct Evidence: marker/mechanism

PMID:20864642 PMID:21063030

NCBI chr 1:40,261,651...40,355,361
Ensembl chr 1:40,264,240...40,356,417

G

interleukin 1 receptor antagonist

ClinVar Annotator: match by term: Endometriosis

NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506

G

interleukin 36A

ClinVar Annotator: match by term: Endometriosis

NCBI chr 2:24,105,429...24,115,713
Ensembl chr 2:24,105,430...24,115,714

G

interleukin 36B

ClinVar Annotator: match by term: Endometriosis

NCBI chr 2:24,043,184...24,050,115
Ensembl chr 2:24,043,173...24,050,531

G

interleukin 36G

ClinVar Annotator: match by term: Endometriosis

NCBI chr 2:24,076,488...24,083,579
Ensembl chr 2:24,076,488...24,083,580

G

interleukin 36 receptor antagonist

ClinVar Annotator: match by term: Endometriosis

NCBI chr 2:24,166,966...24,172,444
Ensembl chr 2:24,166,966...24,173,438

G

interleukin 7 receptor

CTD Direct Evidence: marker/mechanism

NCBI chr15:9,505,880...9,530,270
Ensembl chr15:9,505,874...9,530,262

G

inositol monophosphatase 2

CTD Direct Evidence: marker/mechanism

NCBI chr18:67,422,246...67,454,375
Ensembl chr18:67,422,256...67,455,542

G

integrin alpha 2

CTD Direct Evidence: marker/mechanism

NCBI chr13:114,969,617...115,068,588
Ensembl chr13:114,969,617...115,068,636

G

integrin beta 1 (fibronectin receptor beta)

CTD Direct Evidence: marker/mechanism

NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681

G

integrin beta 3 binding protein (beta3-endonexin)

CTD Direct Evidence: marker/mechanism

NCBI chr 4:99,655,643...99,717,403
Ensembl chr 4:99,653,639...99,787,010

G

integrin beta 8

CTD Direct Evidence: marker/mechanism

NCBI chr12:119,121,757...119,202,891
Ensembl chr12:119,121,757...119,202,537

G

kinase insert domain protein receptor

mRNA:increased expression:endometrium

RGD

NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118

G

Kruppel-like transcription factor 13

CTD Direct Evidence: marker/mechanism

NCBI chr 7:63,536,099...63,588,663
Ensembl chr 7:63,536,099...63,588,663

G

Kruppel-like transcription factor 9

CTD Direct Evidence: marker/mechanism

NCBI chr19:23,118,590...23,145,493
Ensembl chr19:23,118,590...23,145,498

G

Kirsten rat sarcoma viral oncogene homolog

CTD Direct Evidence: marker/mechanism
OMIM:131200

NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965

G

laminin B1

CTD Direct Evidence: marker/mechanism

NCBI chr12:31,315,230...31,379,643
Ensembl chr12:31,315,233...31,379,643

G

leiomodin 1 (smooth muscle)

CTD Direct Evidence: marker/mechanism

NCBI chr 1:135,252,551...135,295,803
Ensembl chr 1:135,252,545...135,295,803

G

leucine-rich repeat kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chr15:91,556,994...91,700,327
Ensembl chr15:91,557,378...91,700,323

G

lactotransferrin

CTD Direct Evidence: marker/mechanism

NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835

G

LYN proto-oncogene, Src family tyrosine kinase

mRNA:increased expression:uterus

RGD

NCBI chr 4:3,676,865...3,791,613
Ensembl chr 4:3,678,115...3,813,122

G

monoamine oxidase A

CTD Direct Evidence: marker/mechanism

NCBI chr X:16,485,937...16,554,051
Ensembl chr X:16,485,937...16,554,057

G

monoamine oxidase B

CTD Direct Evidence: marker/mechanism

NCBI chr X:16,575,520...16,683,605
Ensembl chr X:16,575,521...16,683,605

G

mitogen-activated protein kinase 8

mRNA:increased expression:peritoneum (human)

NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115

G

midkine

RGD

NCBI chr 2:91,760,149...91,762,348
Ensembl chr 2:91,760,150...91,762,642

G

mediator complex subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:98,042,980...98,084,121
Ensembl chr11:98,042,980...98,084,119

G

mediator complex subunit 14

CTD Direct Evidence: marker/mechanism

NCBI chr X:12,541,607...12,628,813
Ensembl chr X:12,541,608...12,628,312

G

mediator complex subunit 16

CTD Direct Evidence: marker/mechanism

NCBI chr10:79,730,543...79,744,757
Ensembl chr10:79,730,542...79,744,757

G

mediator complex subunit 17

CTD Direct Evidence: marker/mechanism

NCBI chr 9:15,171,647...15,194,576
Ensembl chr 9:15,171,647...15,191,227

G

mediator complex subunit 4

CTD Direct Evidence: marker/mechanism

NCBI chr14:73,747,489...73,755,985
Ensembl chr14:73,747,465...73,756,289

G

microRNA 21a

CTD Direct Evidence: marker/mechanism

NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984

G

matrix metallopeptidase 2

mRNA:increased expression:endometrium

RGD

NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048

G

matrix metallopeptidase 9

mRNA:increased expression:endometrium

RGD

NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770

G

metastasis associated 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:113,061,830...113,100,826
Ensembl chr12:113,061,898...113,100,826

G

metastasis-associated gene family, member 2

CTD Direct Evidence: marker/mechanism

NCBI chr19:8,919,239...8,929,659
Ensembl chr19:8,919,239...8,929,667

G

myosin regulatory light chain interacting protein

CTD Direct Evidence: marker/mechanism

NCBI chr13:45,543,197...45,565,498
Ensembl chr13:45,543,218...45,565,498

G

nuclear receptor coactivator 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:4,297,362...4,569,452
Ensembl chr12:4,297,362...4,527,182

G

nuclear receptor coactivator 6

CTD Direct Evidence: marker/mechanism

NCBI chr 2:155,232,585...155,315,741
Ensembl chr 2:155,232,576...155,315,814

G

nuclear receptor co-repressor 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:62,207,132...62,348,200
Ensembl chr11:62,207,252...62,349,367

G

neuron-derived neurotrophic factor

CTD Direct Evidence: marker/mechanism

NCBI chr 6:65,648,595...65,689,307
Ensembl chr 6:65,648,574...65,689,310

G

neural precursor cell expressed, developmentally down-regulated gene 4-like

CTD Direct Evidence: marker/mechanism

NCBI chr18:65,017,551...65,350,888
Ensembl chr18:65,020,776...65,350,899

G

neurofilament, medium polypeptide

CTD Direct Evidence: marker/mechanism

NCBI chr14:68,356,994...68,362,453
Ensembl chr14:68,320,039...68,362,295

G

nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha

RGD

NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432

G

nuclear receptor subfamily 1, group D, member 2

CTD Direct Evidence: marker/mechanism

NCBI chr14:4,230,549...4,265,639
Ensembl chr14:4,230,569...4,265,642

G

nuclear receptor subfamily 2, group C, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:93,983,491...94,033,078
Ensembl chr10:93,983,885...94,033,073

G

nuclear receptor subfamily 2, group C, member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:92,068,426...92,150,039
Ensembl chr 6:92,068,371...92,151,275

G

nuclear receptor subfamily 2, group F, member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:70,001,694...70,016,494
Ensembl chr 7:70,001,692...70,016,483

G

nuclear receptor subfamily 2, group F, member 6

CTD Direct Evidence: marker/mechanism

NCBI chr 8:71,826,762...71,834,593
Ensembl chr 8:71,826,767...71,834,604

G

nuclear receptor subfamily 3, group C, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474

G

nuclear receptor subfamily 3, group C, member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641

G

nuclear receptor subfamily 4, group A, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr15:101,151,783...101,172,676
Ensembl chr15:101,152,150...101,172,676

G

nuclear receptor subfamily 5, group A, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:38,582,668...38,604,554
Ensembl chr 2:38,582,668...38,604,554

G

neuropilin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:129,085,553...129,231,957
Ensembl chr 8:129,085,085...129,229,844

G

neurotrophic tyrosine kinase, receptor, type 1

mRNA, protein:increased expression:spinal ganglia, uterus

RGD

NCBI chr 3:87,685,551...87,702,549
Ensembl chr 3:87,685,551...87,702,469

G

neurotrophic tyrosine kinase, receptor, type 3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:77,825,711...78,228,865
Ensembl chr 7:77,825,707...78,387,760

G

olfactomedin 4

CTD Direct Evidence: marker/mechanism

NCBI chr14:80,237,742...80,260,581
Ensembl chr14:80,221,521...80,260,579

G

odd-skipped related 2

CTD Direct Evidence: marker/mechanism

NCBI chr15:35,296,244...35,303,451
Ensembl chr15:35,296,244...35,303,451

G

pregnancy-associated plasma protein A

CTD Direct Evidence: marker/mechanism

NCBI chr 4:65,041,993...65,276,776
Ensembl chr 4:65,042,411...65,275,746

G

paired box 2

CTD Direct Evidence: marker/mechanism

NCBI chr19:44,735,040...44,826,708
Ensembl chr19:44,735,057...44,826,310

G

progesterone receptor

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:20864642 PMID:21232532 PMID:21166214 PMID:16126772

RGD:7248704, RGD:1601277

NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612

G

phospholipase A2, group IIA (platelets, synovial fluid)

CTD Direct Evidence: marker/mechanism

NCBI chr 4:138,559,168...138,562,500
Ensembl chr 4:138,559,171...138,562,497

G

polo like kinase 1

mRNA, protein:increased expression

RGD

NCBI chr 7:121,758,658...121,769,107
Ensembl chr 7:121,758,662...121,769,096

G

plexin C1

CTD Direct Evidence: marker/mechanism

NCBI chr10:94,626,728...94,780,875
Ensembl chr10:94,626,728...94,780,697

G

prolactin

CTD Direct Evidence: marker/mechanism

NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188

G

prolactin receptor

CTD Direct Evidence: marker/mechanism

NCBI chr15:10,177,324...10,349,276
Ensembl chr15:10,177,324...10,349,266

G

prostaglandin E receptor 2 (subtype EP2)

CTD Direct Evidence: marker/mechanism

NCBI chr14:45,225,568...45,241,277
Ensembl chr14:45,225,652...45,241,277

G

prostaglandin E receptor 4 (subtype EP4)

CTD Direct Evidence: marker/mechanism

NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668

G

prostaglandin E synthase

mRNA, protein:increased expression:epithelial cell

RGD

NCBI chr 2:30,779,483...30,793,309
Ensembl chr 2:30,779,483...30,819,875

G

prostaglandin F receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 3:151,504,247...151,543,165
Ensembl chr 3:151,502,139...151,543,267

G

prostaglandin-endoperoxide synthase 2

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25446850 PMID:20056215 PMID:23406865

RGD:5135061, RGD:7257718

NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978

G

PTK2 protein tyrosine kinase 2

RGD

NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129

G

protein tyrosine phosphatase, non-receptor type 22 (lymphoid)

RGD

NCBI chr 3:103,763,891...103,819,568
Ensembl chr 3:103,767,111...103,819,563

G

retinoic acid receptor, beta

CTD Direct Evidence: marker/mechanism

NCBI chr14:5,387,365...6,038,924
Ensembl chr14:5,650,540...6,038,924

G

RAS guanyl releasing protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:117,110,464...117,173,358
Ensembl chr 2:117,110,474...117,173,482

G

RAS-like, family 11, member A

CTD Direct Evidence: marker/mechanism

NCBI chr 5:146,781,881...146,784,536
Ensembl chr 5:146,781,881...146,784,537

G

recombination signal binding protein for immunoglobulin kappa J region

CTD Direct Evidence: marker/mechanism

NCBI chr 5:53,713,121...53,814,787
Ensembl chr 5:53,623,494...53,814,704

G

regulator of G-protein signaling 4

CTD Direct Evidence: marker/mechanism

NCBI chr 1:169,569,046...169,575,211
Ensembl chr 1:169,569,046...169,575,211

G

RAR-related orphan receptor beta

CTD Direct Evidence: marker/mechanism

NCBI chr19:18,907,966...19,088,560
Ensembl chr19:18,907,969...19,088,560

G

runt related transcription factor 1

mRNA:increased expression:endometrium

RGD

NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037

G

relaxin/insulin-like family peptide receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:79,548,910...79,645,258
Ensembl chr 3:79,548,918...79,645,187

G

secretoglobin, family 3A, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:49,554,422...49,555,945
Ensembl chr11:49,554,437...49,555,945

G

selenoprotein P

CTD Direct Evidence: marker/mechanism

NCBI chr15:3,300,249...3,309,992
Ensembl chr15:3,298,029...3,309,990

G

selectin, lymphocyte

mRNA:increased expression:endometrium

RGD

NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750

G

serine (or cysteine) peptidase inhibitor, clade F, member 1

treatment

human protein in a rat model
protein:decreased expression:endometrium (rat)

RGD

PMID:23466670 PMID:22975116

RGD:8590225, RGD:8638001

NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527

G

solute carrier family 16 (monocarboxylic acid transporters), member 6

CTD Direct Evidence: marker/mechanism

NCBI chr11:109,341,681...109,366,428
Ensembl chr11:109,341,681...109,364,424

G

solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:28,812,535...28,891,360
Ensembl chr19:28,812,449...28,891,360

G

solute carrier family 20, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:129,038,662...129,053,535
Ensembl chr 2:129,040,684...129,053,536

G

solute carrier family 40 (iron-regulated transporter), member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683

G

solute carrier family 7 (cationic amino acid transporter, y+ system), member 8

CTD Direct Evidence: marker/mechanism

NCBI chr14:54,959,672...55,019,343
Ensembl chr14:54,959,666...55,019,403

G

sphingomyelin phosphodiesterase, acid-like 3A

CTD Direct Evidence: marker/mechanism

NCBI chr10:57,670,640...57,687,926
Ensembl chr10:57,670,431...57,687,926

G

SPARC-like 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:104,226,974...104,261,954
Ensembl chr 5:104,226,977...104,261,599

G

serine peptidase inhibitor, Kazal type 1

disease_progression

protein:increased expression:serum

RGD

NCBI chr18:43,861,134...43,870,302
Ensembl chr18:43,861,147...43,870,622

G

steroid 5 alpha-reductase 1

CTD Direct Evidence: marker/mechanism

PMID:21232532 PMID:23183084

NCBI chr13:69,721,568...69,759,611
Ensembl chr13:69,721,568...69,759,561

G

steroid 5 alpha-reductase 2

CTD Direct Evidence: marker/mechanism

NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911

G

somatostatin

CTD Direct Evidence: marker/mechanism

NCBI chr16:23,708,327...23,710,041
Ensembl chr16:23,708,323...23,709,708

G

stanniocalcin 2

CTD Direct Evidence: marker/mechanism

NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074

G

succinate-Coenzyme A ligase, GDP-forming, beta subunit

CTD Direct Evidence: marker/mechanism

NCBI chr 6:95,449,992...95,695,799
Ensembl chr 6:95,449,990...95,695,781

G

sulfatase 2

CTD Direct Evidence: marker/mechanism

PMID:20864642 PMID:21063030

NCBI chr 2:165,915,819...165,997,603
Ensembl chr 2:165,915,009...165,997,583

G

tumor-associated calcium signal transducer 2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:67,511,043...67,512,806
Ensembl chr 6:67,511,046...67,512,780

G

transgelin

CTD Direct Evidence: marker/mechanism

NCBI chr 9:45,840,926...45,847,356
Ensembl chr 9:45,840,917...45,847,356

G

transforming growth factor, beta 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186

G

thyroid hormone receptor alpha

CTD Direct Evidence: marker/mechanism

NCBI chr11:98,631,539...98,659,832
Ensembl chr11:98,631,464...98,659,832

G

thiol methyltransferase 1A1

CTD Direct Evidence: marker/mechanism

NCBI chr15:100,201,969...100,227,882
Ensembl chr15:100,202,021...100,226,543

G

tenascin C

CTD Direct Evidence: marker/mechanism

NCBI chr 4:63,878,022...63,965,554
Ensembl chr 4:63,878,022...63,965,252

G

tumor necrosis factor

treatment

ClinVar Annotator: match by term: Endometriosis
protein:increased expression:peritoneal fluid

PMID:8056188 PMID:9818939 PMID:10450718 PMID:11261930 PMID:11506397 More...

RGD:7247423, RGD:10395305

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

G

tumor necrosis factor receptor superfamily, member 1b

treatment

human protein in rat model

RGD

PMID:21481092 PMID:21741153

RGD:5131251, RGD:7247423

NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440

G

transducer of ErbB-2.1

CTD Direct Evidence: marker/mechanism

NCBI chr11:94,100,668...94,106,321
Ensembl chr11:94,102,280...94,106,321

G

thyrotropin releasing hormone

CTD Direct Evidence: marker/mechanism

NCBI chr 6:92,219,042...92,221,631
Ensembl chr 6:92,219,042...92,221,631

G

thioredoxin interacting protein

CTD Direct Evidence: marker/mechanism

NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199

G

uronyl-2-sulfotransferase

CTD Direct Evidence: marker/mechanism

NCBI chr10:8,068,499...8,394,701
Ensembl chr10:8,080,520...8,394,589

G

vav 1 oncogene

mRNA:increased expression:endometrium

RGD

NCBI chr17:57,586,080...57,636,236
Ensembl chr17:57,586,100...57,635,031

G

versican

CTD Direct Evidence: marker/mechanism

NCBI chr13:89,803,429...89,891,146
Ensembl chr13:89,803,431...89,890,628

G

vascular endothelial growth factor A

mRNA:increased expression:endometrium

RGD

NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295

G

vasoactive intestinal polypeptide

RGD

NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617

endometrial adenocarcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

angiopoietin 1

protein:increased expression:endometrium epithelium

RGD

NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373

G

angiopoietin 2

protein:increased expression:endometrium epithelium

RGD

NCBI chr 8:18,740,279...18,791,578
Ensembl chr 8:18,740,279...18,791,578

G

AT-rich interaction domain 1A

treatment

human cell in mouse model

RGD

NCBI chr 4:133,406,319...133,484,682
Ensembl chr 4:133,406,319...133,484,080

G

axin 2

RGD

NCBI chr11:108,808,687...108,841,609
Ensembl chr11:108,811,175...108,841,609

G

Bet1 golgi vesicular membrane trafficking protein like

disease_progression

RGD

NCBI chr 7:140,433,297...140,437,306
Ensembl chr 7:140,433,307...140,437,490

G

CD55 molecule, decay accelerating factor for complement

RGD

NCBI chr 1:130,357,526...130,390,513
Ensembl chr 1:130,366,764...130,390,481

G

estrogen receptor-binding fragment-associated gene 9

protein:increased expression:endometrium

RGD

NCBI chr15:44,482,574...44,504,916
Ensembl chr15:44,482,571...44,504,911

G

forkhead box O3

severity

associated with Obesity;protein:decreased expression:endometrium (human)

RGD

NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751

G

glutathione peroxidase 3

mRNA:decreased expression:endometrium (rat)

RGD

NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203

G

interferon regulatory factor 1

DNA:deletions (rat)

RGD

NCBI chr11:53,660,841...53,669,200
Ensembl chr11:53,660,841...53,669,200

G

jun proto-oncogene

no_association

RGD

NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459

G

Kirsten rat sarcoma viral oncogene homolog

DNA:point mutation:CDS:p.G12D, p.G12S, p.Q61H (rat)

RGD

NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965

G

mitogen-activated protein kinase 1

treatment

human tumor in a mouse model
protein:decreased phosphorylation:endometrium (human)

RGD

PMID:23402905 PMID:14760076

RGD:13703125, RGD:13703137

NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317

G

mitogen-activated protein kinase 3

treatment

human tumor in a mouse model
protein:decreased phosphorylation:endometrium (human)

RGD

PMID:23402905 PMID:14760076

RGD:13703125, RGD:13703137

NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991

G

programmed cell death 10

disease_progression

protein:increased expression:endometrium (human)

RGD

NCBI chr 3:75,423,797...75,464,159
Ensembl chr 3:75,423,797...75,464,163

G

phosphoinositide-3-kinase regulatory subunit 1

DNA:mutations:multiple (human)

RGD

NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725

G

phosphatase and tensin homolog

ameliorates

RGD

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

prostaglandin E synthase

protein:increased expression:endometrium

RGD

NCBI chr 2:30,779,483...30,793,309
Ensembl chr 2:30,779,483...30,819,875

G

ribonucleotide reductase M2

DNA:amplification (rat)

RGD

NCBI chr12:24,758,253...24,764,145
Ensembl chr12:24,758,240...24,764,145

G

transforming growth factor, beta receptor III

mRNA:decreased expression:endometrium

RGD

NCBI chr 5:107,254,433...107,437,495
Ensembl chr 5:107,254,436...107,437,495

G

transformation related protein 53

disease_progression

DNA:missense mutations
protein:increased expression:endometrium

PMID:1540970 PMID:1540970

RGD:2290541, RGD:2290541

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

tumor susceptibility gene 101

mRNA:alternative forms

RGD

NCBI chr 7:46,538,693...46,569,716
Ensembl chr 7:46,538,697...46,569,717

endometrial cancer

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adrenergic receptor, beta 3

susceptibility

associated with Obesity;DNA:polymorphism: :p.W64R (human)

RGD

NCBI chr 8:27,715,804...27,720,833
Ensembl chr 8:27,715,804...27,740,644

G

alpha fetoprotein

severity

protein:increased expression:serum

RGD

NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766

G

thymoma viral proto-oncogene 2

severity

DNA:snp:intron:c.287+993G>A (rs892119) (human)

RGD

NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251

G

angiogenin, ribonuclease, RNase A family, 5

protein:increased expression:serum

RGD

NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466

G

APC, WNT signaling pathway regulator

severity
treatment

with Pten knockout
protein:increased expression:endometrium (human)
DNA:mutations, haplotype:cds:multiple (human)
human cells in a mouse model

RGD

PMID:23288720 PMID:15951972 PMID:29876005 PMID:22907428

RGD:13524585, RGD:13673917, RGD:13673916, RGD:13524624

NCBI chr18:34,353,350...34,455,243
Ensembl chr18:34,353,977...34,455,605

G

apurinic/apyrimidinic endonuclease 1

DNA:nonsense mutation, missense mutations: :p.W188X, p.P112L, p.R237C (human)

RGD

NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596

G

androgen receptor

RGD

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

AT-rich interaction domain 1A

onset

protein:decreased expression:endometrium (human)

NCBI chr 4:133,406,319...133,484,682
Ensembl chr 4:133,406,319...133,484,080

G

ataxia telangiectasia mutated

susceptibility

RGD

NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040

G

BCL2-associated agonist of cell death

disease progression

protein:altered expression:endometrium (human)

RGD

NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267

G

BCL2-associated athanogene 1

protein:increased expression:endometrium

RGD

NCBI chr 4:40,936,398...40,948,294
Ensembl chr 4:40,936,398...40,948,294

G

BCL2-like 1

protein:increased expression:endometrium

RGD

NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648

G

breast cancer 2, early onset

DNA:deletion, frameshift mutation

RGD

NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794

G

bone marrow stromal cell antigen 2

treatment

protein:increased expression:endometrium:

RGD

PMID:26498112 PMID:22729361 PMID:22729361

RGD:14398492, RGD:14398498, RGD:14398498

NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100

G

CD59b antigen

protein:increased expression:endometrium

RGD

NCBI chr 2:103,900,127...103,920,619
Ensembl chr 2:103,896,142...103,921,534

G

CD9 antigen

RGD

NCBI chr 6:125,437,229...125,471,723
Ensembl chr 6:125,437,229...125,471,754

G

cell division cycle 25B

RGD

NCBI chr 2:131,028,356...131,040,431
Ensembl chr 2:131,028,869...131,040,417

G

cell division cycle 25C

DNA:mutation (human)

RGD

NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586

G

cadherin 1

NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878

G

cyclin dependent kinase inhibitor 2A

DNA:deletions:exon (rat)

RGD

NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890

G

cyclin dependent kinase inhibitor 2B

DNA:deletion (rat)

RGD

NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276

G

chitinase 3 like 1

severity

protein:increased secretion:serum (human)

RGD

NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919

G

catechol-O-methyltransferase

susceptibility
no_association

DNA:hypermethylation:promoter
DNA:polymorphism: :p.V158M

RGD

PMID:12810635 PMID:17442187 PMID:15285606

RGD:2289723, RGD:2289714, RGD:2289721

NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602

G

cytochrome P450, family 19, subfamily a, polypeptide 1

DNA:SNP::increase in frequency of mutant heterozygote C/T (p=0.0004)

RGD

NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394

G

cytochrome P450, family 1, subfamily a, polypeptide 1

RGD

NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107

G

cytochrome P450, family 1, subfamily a, polypeptide 2

RGD

NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986

G

dihydrofolate reductase

ClinVar Annotator: match by term: MSH3-related condition

PMID:25741868 PMID:26467025 PMID:28492532 PMID:29641532 PMID:36652909

NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561

G

epidermal growth factor-containing fibulin-like extracellular matrix protein 2

exacerbates
ameliorates

protein:decreased expression:endometrium (human)
human EFEMP2 knockdown cell line in a mouse model

RGD

PMID:28177909 PMID:28177909

RGD:42722012, RGD:42722012

NCBI chr19:5,523,974...5,532,548
Ensembl chr19:5,523,982...5,532,545

G

epidermal growth factor

severity

DNA:snps:5'utr:multiple (human)

RGD

NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965

G

ERBB receptor feedback inhibitor 1

OMIM:608089

NCBI chr 4:150,938,253...150,953,346
Ensembl chr 4:150,938,376...150,953,349

G

fibroblast growth factor 1

disease_progression

mRNA:increased expression:myometrium

RGD

NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525

G

fibroblast growth factor 2

disease_progression

mRNA, protein:increased expression:myometrium

RGD

NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257

G

growth hormone releasing hormone

mRNA:increased expression:tumor:expression in 17/22 specimens

RGD

PMID:10022420 PMID:15784701

RGD:2289974, RGD:2301423

NCBI chr 2:157,171,416...157,190,645
Ensembl chr 2:157,171,417...157,189,426

G

homeobox B13

RGD

NCBI chr11:96,085,142...96,087,436
Ensembl chr11:96,085,142...96,088,273

G

HtrA serine peptidase 2

protein:decreased expression:endometrium (human)

RGD

NCBI chr 6:83,028,247...83,031,552
Ensembl chr 6:83,028,247...83,032,254

G

interleukin 10

protein:increased expression:serum

RGD

NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711

G

Janus kinase 1

severity

DNA:frameshift mutations

RGD

NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479

G

junction plakoglobin

protein:decreased expression:endometrium

RGD

NCBI chr11:100,259,682...100,288,639
Ensembl chr11:100,259,784...100,288,589

G

lymphotoxin A

susceptibility

DNA:polymorphism: :252A>G, 804C>A (human)

RGD

NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327

G

microcephaly, primary autosomal recessive 1

DNA:deletions:exons:multiple (human)

RGD

NCBI chr 8:18,645,132...18,858,110
Ensembl chr 8:18,645,147...18,853,205

G

microRNA 21a

miRNA:increased expression:endometrium

RGD

NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984

G

mutL homolog 3

ClinVar Annotator: match by term: Endometrial cancer

PMID:12702580 PMID:28195393 PMID:28492532 PMID:31297992

NCBI chr12:85,281,240...85,317,421
Ensembl chr12:85,281,294...85,317,373

G

matrix metallopeptidase 7

disease_progression

protein:increased expression:endometrium

RGD

NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,587

G

MRE11A homolog A, double strand break repair nuclease

DNA:deletions:intron:IVS4_delT (human)

RGD

NCBI chr 9:14,695,971...14,748,421
Ensembl chr 9:14,695,950...14,748,419

G

mutS homolog 3

ClinVar Annotator: match by term: MSH3-related condition

PMID:2635641 PMID:8782829 PMID:11470537 PMID:20981092 PMID:21128252 More...

NCBI chr13:92,348,387...92,491,515
Ensembl chr13:92,348,380...92,491,511

G

mutS homolog 6

NCBI chr17:88,282,478...88,298,320
Ensembl chr17:88,282,490...88,298,320

G

mutY DNA glycosylase

ClinVar Annotator: match by term: Endometrial cancer, somatic

PMID:2914711 PMID:11818965 PMID:12606733 PMID:12917422 PMID:15036665 More...

NCBI chr 4:116,664,846...116,676,641
Ensembl chr 4:116,664,920...116,676,637

G

notch 1

mRNA:increased expression:endometrium

RGD

NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675

G

notch 4

mRNA:decreased expression:endometrium

RGD

NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477

G

phosphoglucomutase 1

NCBI chr 4:99,786,648...99,844,491
Ensembl chr 4:99,786,611...99,844,491

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta

onset

mRNA:increased expression:endometrium (human)

RGD

NCBI chr 9:98,920,455...99,022,264
Ensembl chr 9:98,918,707...99,022,674

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta

RGD

NCBI chr 4:149,733,625...149,787,023
Ensembl chr 4:149,733,625...149,787,028

G

phosphoinositide-3-kinase regulatory subunit 1

DNA:mutations:multiple (human)

RGD

NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725

G

polymerase (DNA directed), epsilon

onset
disease_progression
ameliorates

DNA:polymorphisms:multiple (human)
protein:increased expression:endometrium (human)
DNA:missense mutations:CDS:p.P286R, p.V411L (human)
DNA:missense mutations:multiple (human)

PMID:31866764 PMID:25224212 PMID:29659608 PMID:29559562

RGD:151347644, RGD:151347645, RGD:151347857, RGD:151347650

NCBI chr 5:110,434,185...110,485,319
Ensembl chr 5:110,434,172...110,485,340

G

phosphatase and tensin homolog

OMIM:608089

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

RAD21 cohesin complex component

onset

DNA:CNV: (human)

RGD

NCBI chr15:51,826,000...51,856,934
Ensembl chr15:51,825,636...51,855,143

G

ring finger protein 43

DNA:mutations:multiple: (human)

RGD

NCBI chr11:87,553,913...87,626,365
Ensembl chr11:87,553,548...87,626,365

G

runt related transcription factor 1

mRNA:decreased expression:endometrium

RGD

NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037

G

sex hormone binding globulin

DNA:polymorphism:exon:p.D327N (human)

RGD

NCBI chr11:69,501,108...69,508,852
Ensembl chr11:69,505,630...69,508,731

G

SMAD family member 2

protein:increased expression:endometrium

RGD

NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034

G

SMAD family member 3

protein:increased expression:endometrium

RGD

NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276

G

SMAD family member 7

disease_progression

mRNA:increased expression:endometrium

RGD

NCBI chr18:75,500,436...75,529,006
Ensembl chr18:75,500,600...75,529,006

G

suppressor of cytokine signaling 2

DNA:hypermethylated

RGD

NCBI chr10:95,219,765...95,253,176
Ensembl chr10:95,221,224...95,253,042

G

sperm associated antigen 9

protein:increased expression:serum:

RGD

NCBI chr11:93,886,794...94,016,919
Ensembl chr11:93,886,917...94,016,911

G

serine/threonine kinase 11

OMIM:608089

PMID:18245476 PMID:18245476

RGD:2291944, RGD:2291944

NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516

G

sulfotransferase family 1A, phenol-preferring, member 1

RGD

NCBI chr 7:126,272,042...126,289,615
Ensembl chr 7:126,272,037...126,275,604

G

sulfotransferase family 1E, member 1

RGD

NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453

G

trefoil factor 1

mRNA, protein:increased expression:endometrium

RGD

NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251

G

tissue inhibitor of metalloproteinase 4

mRNA:decreased expression:endometrium

RGD

NCBI chr 6:115,221,405...115,229,166
Ensembl chr 6:115,218,853...115,229,166

G

tumor necrosis factor receptor superfamily, member 1a

protein:increased expression:serum (human)

RGD

NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447

G

tumor necrosis factor receptor superfamily, member 1b

protein:increased expression:serum (human)

RGD

NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440

G

transformation related protein 53

OMIM:608089

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

thymidine phosphorylase

RGD

NCBI chr15:89,255,834...89,261,282
Ensembl chr15:89,256,134...89,261,242

G

UDP glucuronosyltransferase 1 family, polypeptide A1

DNA:SNP: :rs2070959 (human)

RGD

NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719

G

WT1 transcription factor

disease_progression

RGD

NCBI chr 2:104,956,874...105,003,959
Ensembl chr 2:104,956,874...105,003,961

endometrial carcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RIKEN cDNA 4930550C14 gene

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:12810666 PMID:19781682 PMID:21787400 PMID:23555315 PMID:25085752 More...

NCBI chr 9:53,313,814...53,345,726
Ensembl chr 9:53,313,625...53,345,702

G

ATP-binding cassette, sub-family A member 3

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,570,997...24,629,178
Ensembl chr17:24,570,924...24,629,175

G

APC, WNT signaling pathway regulator

onset

DNA:hypermethylation:promoter: (human)
ClinVar Annotator: match by term: Endometrial carcinoma

PMID:25741868 PMID:28492532 PMID:32885271 PMID:19900189 PMID:21363919

RGD:13524625, RGD:13525011

NCBI chr18:34,353,350...34,455,243
Ensembl chr18:34,353,977...34,455,605

G

apoptosis resistant E3 ubiquitin protein ligase 1

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:12702580 PMID:17656264 PMID:22290698 PMID:25741868 PMID:28492532

NCBI chr12:84,964,914...85,017,674
Ensembl chr12:84,964,922...85,017,674

G

AT-rich interaction domain 1A

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr 4:133,406,319...133,484,682
Ensembl chr 4:133,406,319...133,484,080

G

ataxia telangiectasia mutated

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:133608 PMID:1300551 PMID:8845835 PMID:8968760 PMID:10425038 More...

NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040

G

aurora kinase A

mRNA, protein:increased expression:endometrium

RGD

NCBI chr 2:172,198,116...172,212,825
Ensembl chr 2:172,198,110...172,212,455

G

aurora kinase B

disease_progression

mRNA, protein:increased expression:endometrium

RGD

NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490

G

BRCA1 associated RING domain 1

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:20077502 PMID:21344236 PMID:25330149 PMID:25741868 PMID:25980754 More...

NCBI chr 1:71,066,694...71,142,300
Ensembl chr 1:71,066,657...71,142,305

G

Braf transforming gene

DNA:missense mutations, nonsense mutation:cds:multiple (human)
ClinVar Annotator: match by term: Endometrial carcinoma

PMID:28492532 PMID:16144912

NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397

G

breast cancer 1, early onset

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:7545954 PMID:7581445 PMID:7837387 PMID:7894492 PMID:8531967 More...

NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781

G

breast cancer 2, early onset

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:8075631 PMID:8524414 PMID:8673091 PMID:8673092 PMID:8758903 More...

NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794

G

BRICHOS domain containing 5

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,692,858...24,694,443
Ensembl chr17:24,692,858...24,694,443

G

basigin

disease_progression

protein:increased expression:endometrium

RGD

NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803

G

CASK interacting protein 1

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,706,871...24,727,883
Ensembl chr17:24,707,575...24,727,645

G

cyclin B1

RGD

NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078

G

CD82 antigen

disease_progression

RGD

NCBI chr 2:93,249,447...93,293,295
Ensembl chr 2:93,249,456...93,293,485

G

cadherin 1

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:2449335 PMID:3028782 PMID:8075649 PMID:9537325 PMID:9744472 More...

NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878

G

cadherin 13

disease_progression

DNA:hypomethylation

RGD

NCBI chr 8:119,010,150...120,051,668
Ensembl chr 8:119,010,472...120,051,660

G

checkpoint kinase 2

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:9536098 PMID:12533788 PMID:15087378 PMID:15095295 PMID:15492928 More...

NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011

G

dihydrofolate reductase

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:9536098 PMID:17576681 PMID:20154325 PMID:25741868 PMID:26467025 More...

NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561

G

deoxyribonuclease 1-like 2

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,659,054...24,662,075
Ensembl chr17:24,659,055...24,662,079

G

E4F transcription factor 1

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,662,752...24,674,366
Ensembl chr17:24,662,752...24,689,287

G

enoyl-Coenzyme A delta isomerase 1

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,645,657...24,658,290
Ensembl chr17:24,645,615...24,658,322

G

epidermal growth factor receptor

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158

G

endoplasmic reticulum aminopeptidase 1

disease_progression

RGD

NCBI chr13:74,787,692...74,841,321
Ensembl chr13:74,787,687...74,841,320

G

fibroblast growth factor 7

mRNA:decreased expression:endometrium

RGD

NCBI chr 2:125,876,578...125,933,105
Ensembl chr 2:125,876,578...125,933,105

G

fibroblast growth factor receptor 2

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:7719344 PMID:8651276 PMID:8696350 PMID:9002682 PMID:9462761 More...

NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079

G

fibroblast growth factor receptor 3

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412

G

growth factor receptor bound protein 2

severity

Shc-Grb2 complex;protein:increased expression:serum (human)

RGD

NCBI chr11:115,534,871...115,599,423
Ensembl chr11:115,534,871...115,599,423

G

glycogen synthase kinase 3 beta

severity

protein:increased expression:endometrium (human)

RGD

NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446

G

H19, imprinted maternally expressed transcript

severity

mRNA:increased expression:endometrium

RGD

NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,133,957

G

histone deacetylase 3

disease_progression

RGD

NCBI chr18:38,070,024...38,088,073
Ensembl chr18:38,068,897...38,088,069

G

Harvey rat sarcoma virus oncogene

disease_progression

protein:increased expression:endometrial stroma, cytoplasm (human)
DNA:snps:cds: (human)

RGD

PMID:9641239 PMID:8960147

RGD:13441555, RGD:13781876

NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918

G

jun proto-oncogene

disease_progression

RGD

NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459

G

KiSS-1 metastasis-suppressor

disease_progression

mRNA:decreased expression:endometrium

RGD

NCBI chr 1:133,249,625...133,257,460
Ensembl chr 1:133,237,565...133,257,460
Ensembl chr 1:133,237,565...133,257,460

G

Kirsten rat sarcoma viral oncogene homolog

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:6320174 PMID:11745231 PMID:15696205 PMID:16051643 PMID:16474405 More...

NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965

G

mitogen-activated protein kinase 1

severity

protein:increased expression:endometrium (human)
protein:increased phosphorylation:endometrium (human)

RGD

PMID:29081408 PMID:22459351

RGD:13702082, RGD:13441552

NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317

G

mitogen-activated protein kinase 3

severity

protein:increased expression:endometrium (human)
protein:increased phosphorylation:endometrium (human)

RGD

PMID:29081408 PMID:22459351

RGD:13702082, RGD:13441552

NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991

G

microRNA 152

DNA:hypermethylation

RGD

NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291

G

mutL homolog 1

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:1756143 PMID:7728749 PMID:8566964 PMID:8571956 PMID:8574961 More...

NCBI chr 9:111,057,296...111,100,854
Ensembl chr 9:111,057,296...111,100,859

G

mutL homolog 3

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:12702580 PMID:16199547 PMID:17656264 PMID:22290698 PMID:25741868 More...

NCBI chr12:85,281,240...85,317,421
Ensembl chr12:85,281,294...85,317,373

G

MTOR associated protein, LST8 homolog (S. cerevisiae)

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,692,524...24,698,722
Ensembl chr17:24,692,525...24,698,052

G

matrix metallopeptidase 8

RGD

NCBI chr 9:7,558,430...7,568,487
Ensembl chr 9:7,558,457...7,568,486

G

matrix metallopeptidase 9

disease_progression

protein:increased expression:endometrium

RGD

NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770

G

mutS homolog 2

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:1586275 PMID:7585065 PMID:8640829 PMID:9222765 PMID:9536098 More...

NCBI chr17:87,979,960...88,031,141
Ensembl chr17:87,979,758...88,031,141

G

mutS homolog 3

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:2635641 PMID:8782829 PMID:9536098 PMID:16199547 PMID:17576681 More...

NCBI chr13:92,348,387...92,491,515
Ensembl chr13:92,348,380...92,491,511

G

mutS homolog 6

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:183784 PMID:183865 PMID:216699 PMID:503524 PMID:580154 More...

NCBI chr17:88,282,478...88,298,320
Ensembl chr17:88,282,490...88,298,320

G

mutY DNA glycosylase

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:11818965 PMID:12606733 PMID:15987719 PMID:16140997 PMID:16338133 More...

NCBI chr 4:116,664,846...116,676,641
Ensembl chr 4:116,664,920...116,676,637

G

nuclear receptor coactivator 1

mRNA:increased expression:endometrium

RGD

NCBI chr12:4,297,362...4,569,452
Ensembl chr12:4,297,362...4,527,182

G

nuclear receptor co-repressor 2

mRNA:increased expression:endometrium

RGD

NCBI chr 5:125,094,217...125,256,302
Ensembl chr 5:125,094,217...125,256,283

G

nitric oxide synthase 3, endothelial cell

disease_progression

protein:increased expression:endometrium

RGD

NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472

G

partner and localizer of BRCA2

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:17200668 PMID:20091115 PMID:21285249 PMID:21365267 PMID:22241545 More...

NCBI chr 7:121,706,485...121,732,203
Ensembl chr 7:121,706,485...121,732,208

G

phosphoglycolate phosphatase

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,689,400...24,692,084
Ensembl chr17:24,689,366...24,692,084

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635

G

phosphoinositide-3-kinase regulatory subunit 1

DNA:mutations:multiple (human)

RGD

NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725

G

polycystin 1, transient receptor potential channel interacting

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,767,657...24,815,457
Ensembl chr17:24,768,808...24,815,482

G

PMS1 homolog2, mismatch repair system component

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:7628019 PMID:7704024 PMID:8072530 PMID:8993976 PMID:9683794 More...

NCBI chr 5:143,846,379...143,922,538
Ensembl chr 5:143,846,782...143,870,786
Ensembl chr 5:143,846,782...143,870,786

G

polymerase (DNA directed), delta 1, catalytic subunit

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:12376507 PMID:17145065 PMID:25741868 PMID:26467025 PMID:28492532

NCBI chr 7:44,182,168...44,198,239
Ensembl chr 7:44,182,170...44,198,273

G

polymerase (DNA directed), epsilon

ClinVar Annotator: match by term: Endometrial carcinoma
DNA:mutations:multiple (human)

PMID:25741868 PMID:26467025 PMID:27217144 PMID:28492532 PMID:23528559

NCBI chr 5:110,434,185...110,485,319
Ensembl chr 5:110,434,172...110,485,340

G

protein kinase C, alpha

RGD

NCBI chr11:107,824,213...108,237,360
Ensembl chr11:107,824,213...108,234,754

G

phosphatase and tensin homolog

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:1945792 PMID:7728760 PMID:8980400 PMID:9259288 PMID:9326929 More...

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

prostaglandin-endoperoxide synthase 1

disease_progression

RGD

NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284

G

PTK2 protein tyrosine kinase 2

severity

protein:increased expression:endometrium

RGD

NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129

G

RAB26, member RAS oncogene family

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,748,038...24,752,696
Ensembl chr17:24,746,215...24,753,184

G

RAD51 paralog C

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:20400964 PMID:21990120 PMID:24800917 PMID:25741868 PMID:26681312 More...

NCBI chr11:87,267,471...87,295,780
Ensembl chr11:87,267,471...87,295,780

G

Ras association (RalGDS/AF-6) domain family member 1

DNA, protein:hypermethylation, decreased expression:promoter,

RGD

NCBI chr 9:107,428,752...107,439,460
Ensembl chr 9:107,428,754...107,439,466

G

RNA binding protein with serine rich domain 1

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,633,620...24,644,872
Ensembl chr17:24,633,539...24,644,875

G

runt related transcription factor 3

DNA:hypermethylation:promoter

RGD

NCBI chr 4:134,847,956...134,905,301
Ensembl chr 4:134,847,963...134,905,301

G

stratifin

RGD

NCBI chr 4:133,327,867...133,329,163
Ensembl chr 4:133,327,867...133,329,479

G

SMAD family member 4

severity

DNA:substitutions:promoter
mRNA:decreased expression:endometrium

RGD

PMID:10331746 PMID:15385128

RGD:2300009, RGD:2299966

NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851

G

small nucleolar RNA, C/D box 60

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,747,450...24,747,527
Ensembl chr17:24,747,450...24,747,527

G

secreted acidic cysteine rich glycoprotein

DNA, mRNA, protein:hypermethylation, altered expression

RGD

NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009

G

serine/threonine kinase 11

ClinVar Annotator: match by term: Endometrial carcinoma

PMID:25741868 PMID:26467025 PMID:28492532

NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516

G

transforming, acidic coiled-coil containing protein 3

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr 5:33,814,808...33,836,331
Ensembl chr 5:33,815,472...33,836,339

G

testin LIM domain protein

severity
exacerbates

RGD

PMID:24929083 PMID:24929083

RGD:597621666, RGD:597621666

NCBI chr 6:17,065,148...17,105,824
Ensembl chr 6:17,065,148...17,105,827

G

trefoil factor 1

disease_progression

protein:increased expression:endometrium

RGD

NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251

G

tissue inhibitor of metalloproteinase 1

disease_progression

protein:increased expression:endometrium

RGD

NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974

G

tissue inhibitor of metalloproteinase 2

disease_progression

mRNA:decreased expression:endometrium

RGD

NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566

G

tissue inhibitor of metalloproteinase 4

disease_progression

protein:increased expression:endometrium

RGD

NCBI chr 6:115,221,405...115,229,166
Ensembl chr 6:115,218,853...115,229,166

G

TNF receptor-associated factor 7

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,727,824...24,746,912
Ensembl chr17:24,727,536...24,746,912

G

transformation related protein 53

severity

protein:increased expression:epithelial cell, endometrium
ClinVar Annotator: match by term: Endometrial carcinoma
DNA:mutations: :

PMID:25741868 PMID:28492532 PMID:18431720 PMID:26353976

RGD:2298525, RGD:11075084

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

TSC complex subunit 2

ClinVar Annotator: match by term: Endometrial carcinoma

NCBI chr17:24,814,788...24,851,607
Ensembl chr17:24,814,790...24,851,604

G

wingless-type MMTV integration site family, member 2

mRNA:decreased expression:endometrium

RGD

NCBI chr 6:17,988,939...18,032,771
Ensembl chr 6:17,988,939...18,030,584

G

wingless-type MMTV integration site family, member 3

RGD

NCBI chr11:103,665,000...103,708,854
Ensembl chr11:103,664,976...103,708,783

G

wingless-type MMTV integration site family, member 4

RGD

NCBI chr 4:137,004,946...137,026,812
Ensembl chr 4:137,004,800...137,027,037

G

wingless-type MMTV integration site family, member 5A

RGD

NCBI chr14:28,224,962...28,249,405
Ensembl chr14:28,226,707...28,249,405

endometrial serous adenocarcinoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ataxia telangiectasia mutated

ClinVar Annotator: match by term: Uterine corpus serous adenocarcinoma

NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040

G

breast cancer 2, early onset

susceptibility

DNA:deletion: :6174delT

RGD

NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794

G

mutS homolog 6

ClinVar Annotator: match by term: Papillary carcinoma of the corpus uteri

PMID:18269114 PMID:21642682 PMID:24362816 PMID:25741868 PMID:28492532 More...

NCBI chr17:88,282,478...88,298,320
Ensembl chr17:88,282,490...88,298,320

endometrial stromal sarcoma

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

KIT proto-oncogene receptor tyrosine kinase

RGD

NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382

Endometrioid Carcinomas

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

APC, WNT signaling pathway regulator

DNA:hypermethylation: (human)

RGD

NCBI chr18:34,353,350...34,455,243
Ensembl chr18:34,353,977...34,455,605

G

amphiregulin

mRNA, protein:increased expression:endometrium

RGD

NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291

G

ATPase, copper transporting, beta polypeptide

disease_progression

protein:increased expression:endometrium

RGD

NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321

G

baculoviral IAP repeat-containing 5

protein:increased expression:endometrium

RGD

NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569

G

bone morphogenetic protein 4

RGD

NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126

G

carbonic anhydrase 9

protein:altered localization:membrane, endometrium

RGD

NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729

G

cyclin E1

protein:increased expression:endometrium

RGD

NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959

G

cadherin 1

protein:decreased expression:endometrium

RGD

NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878

G

cyclin dependent kinase 2

severity

RGD

NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900

G

cyclin dependent kinase inhibitor 1B

RGD

NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476

G

checkpoint kinase 2

susceptibility

RGD

NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011

G

catenin beta 1

DNA:mutations

RGD

NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573

G

Fas death domain-associated protein

protein:increased expression:ovary:

RGD

NCBI chr17:34,128,379...34,134,564
Ensembl chr17:34,128,388...34,134,564

G

DNA methyltransferase 1

mRNA,protein:increased expression:uterus:

RGD

NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184

G

DNA methyltransferase 3B

mRNA,protein:increased expression:uterus:

RGD

NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650

G

epidermal growth factor receptor

mRNA:decreased expression:endometrium

RGD

NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158

G

enolase 2, gamma neuronal

RGD

NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636

G

erb-b2 receptor tyrosine kinase 2

RGD

NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542

G

erb-b2 receptor tyrosine kinase 3

RGD

NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521

G

erb-b2 receptor tyrosine kinase 4

RGD

NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218

G

estrogen receptor 1 (alpha)

severity

protein:increased phosphorylation

RGD

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

fibroblast growth factor receptor 2

RGD

NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079

G

insulin-like growth factor binding protein 3

disease_progression

RGD

NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923

G

inhibin alpha

RGD

NCBI chr 1:75,483,872...75,487,010
Ensembl chr 1:75,483,721...75,487,010

G

inhibin beta-A

protein:decreased expression:endometrium

RGD

NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206

G

kinase insert domain protein receptor

severity

RGD

NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118

G

Kirsten rat sarcoma viral oncogene homolog

associated with Ovarian Neoplasms

RGD

NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965

G

leucyl/cystinyl aminopeptidase

associated with Endometrial Neoplasms

RGD

NCBI chr17:17,747,985...17,846,303
Ensembl chr17:17,741,672...17,845,312

G

mitogen-activated protein kinase 1

treatment

RGD

NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317

G

mitogen-activated protein kinase 3

treatment

RGD

NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991

G

mesothelin

CTD Direct Evidence: marker/mechanism

NCBI chr17:25,967,587...25,973,352
Ensembl chr17:25,967,587...25,973,352

G

NK2 homeobox 1

DNA:hypermethylation

RGD

NCBI chr12:56,578,741...56,583,570
Ensembl chr12:56,578,743...56,583,693

G

platelet derived growth factor receptor, alpha polypeptide

protein:decreased expression:ovary

RGD

NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876

G

platelet derived growth factor receptor, beta polypeptide

protein:increased expression:ovary

RGD

NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133

G

polymerase (DNA directed), epsilon

ameliorates

DNA:mutations:multiple (human)
ClinVar Annotator: match by term: Endometrioid adenocarcinoma

PMID:23263490 PMID:23447401 PMID:24525744 PMID:24844595 PMID:25224212 More...

NCBI chr 5:110,434,185...110,485,319
Ensembl chr 5:110,434,172...110,485,340

G

phosphatase and tensin homolog

DNA:mutations: :multiple
DNA:loss of heterozygosity, mutations:multiple (human)

RGD

PMID:17418409 PMID:11156411

RGD:2289817, RGD:12802357

NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560

G

secreted phosphoprotein 1

RGD

NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916

G

suppression of tumorigenicity 14 (colon carcinoma)

associated with Ovarian Neoplasms;protein:increased expression:ovary

RGD

NCBI chr 9:30,999,886...31,043,138
Ensembl chr 9:31,000,698...31,043,149

G

Wnt inhibitory factor 1

mRNA:increased expression:ovary

RGD

NCBI chr10:120,869,909...120,936,547
Ensembl chr10:120,869,865...120,936,555

endometriosis of pelvic peritoneum

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

CD68 antigen

protein:increased expression:peritoneum (human)

RGD

NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979

endometriosis of uterus

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Bruton agammaglobulinemia tyrosine kinase

disease_progression

RGD

NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319

G

DNA methyltransferase 1

protein:increased expression:ectopic endometrium:

RGD

NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184

G

DNA methyltransferase 3A

protein:decreased expression:endometrium:

RGD

NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443

G

DNA methyltransferase 3B

protein:increased expression:ectopic endometrium:

RGD

NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650

gestational trophoblastic neoplasm

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

natural cytotoxicity triggering receptor 1

ClinVar Annotator: match by term: Gestational trophoblastic neoplasia

NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163

G

POU domain, class 5, transcription factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:35,816,929...35,821,674
Ensembl chr17:35,816,915...35,821,669

Hydatidiform Mole

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

glycoprotein hormones, alpha subunit

protein:increased expression:serum

RGD

NCBI chr 4:34,893,779...34,907,374
Ensembl chr 4:34,893,779...34,907,370

G

elongation factor Tu GTP binding domain containing 2

protein:increased expression:trophoblast, decidua:

RGD

NCBI chr11:102,729,298...102,771,999
Ensembl chr11:102,729,299...102,771,811

G

KH domain containing 3, subcortical maternal complex member

CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hydatidiform mole

NCBI chr 9:73,008,660...73,013,915
Ensembl chr 9:73,009,118...73,011,720

G

mutL homolog 1

DNA, protein:hypermethylation, decreased expression:promoter, mononuclear cytotrophoblast cell

RGD

NCBI chr 9:111,057,296...111,100,854
Ensembl chr 9:111,057,296...111,100,859

G

matrix metallopeptidase 2

protein:increased expression:syncytiotrophoblast cell

RGD

NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048

G

mutS homolog 2

DNA, protein:hypermethylation, decreased expression:promoter, mononuclear cytotrophoblast cell

RGD

NCBI chr17:87,979,960...88,031,141
Ensembl chr17:87,979,758...88,031,141

G

natural cytotoxicity triggering receptor 1

ClinVar Annotator: match by term: Hydatidiform mole

PMID:24033266 PMID:25741868

NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163

G

platelet derived growth factor receptor, beta polypeptide

mRNA:increased expression:mononuclear cytotrophoblast cell

RGD

NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133

Hydatidiform Mole, Invasive

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

mutS homolog 2

protein:decreased expression:mononuclear cytotrophoblast cell

RGD

NCBI chr17:87,979,960...88,031,141
Ensembl chr17:87,979,758...88,031,141

Hydatidiform Mole, Recurrent, 1

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

natural cytotoxicity triggering receptor 1

ClinVar Annotator: match by term: Hydatidiform mole, recurrent, 1 | ClinVar Annotator: match by term: NLRP7-related condition

PMID:11598368 PMID:14756744 PMID:16199547 PMID:16239310 PMID:16462743 More...

NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163

Hydatidiform Mole, Recurrent, 2

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

KH domain containing 3, subcortical maternal complex member

ClinVar Annotator: match by term: Hydatidiform mole, recurrent, 2 | ClinVar Annotator: match by term: KHDC3L-related condition

PMID:11932746 PMID:19246479 PMID:21623199 PMID:21885028 PMID:23125094 More...

NCBI chr 9:73,008,660...73,013,915
Ensembl chr 9:73,009,118...73,011,720

Hydatidiform Mole, Recurrent, 3

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

meiotic double-stranded break formation protein 1

ClinVar Annotator: match by term: Hydatidiform mole, recurrent, 3 | ClinVar Annotator: match by term: MEI1-related condition

PMID:25741868 PMID:28492532 PMID:30388401

NCBI chr15:81,954,275...82,011,018
Ensembl chr15:81,954,197...82,011,015

Hydatidiform Mole, Recurrent, 4

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

TOP6B like initiator of meiotic double strand breaks

ClinVar Annotator: match by term: Hydatidiform mole, recurrent, 4 | ClinVar Annotator: match by term: TOP6BL-related condition

PMID:25741868 PMID:28492532 PMID:30388401

NCBI chr19:4,675,758...4,748,753
Ensembl chr19:4,675,762...4,748,696

Term paths to the root

Path 1
Term	Annotations
disease	16263
disease of anatomical entity	15856
reproductive system disease	3173
female reproductive system disease	2171
endometriosis	382
endometrial cancer +	197
endometriosis in scar of skin	0
endometriosis of intestine	0
endometriosis of ovary	0
endometriosis of pelvic peritoneum	1
endometriosis of rectovaginal septum and vagina	0
endometriosis of uterus	4
endosalpingiosis	0
fallopian tube endometriosis	0
Path 2
Term	Annotations
disease	16263
disease of anatomical entity	15856
Urogenital Diseases	5072
Female Urogenital Diseases and Pregnancy Complications	2668
Female Urogenital Diseases	2174
female reproductive system disease	2171
endometriosis	382
endometrial cancer +	197
endometriosis in scar of skin	0
endometriosis of intestine	0
endometriosis of ovary	0
endometriosis of pelvic peritoneum	1
endometriosis of rectovaginal septum and vagina	0
endometriosis of uterus	4
endosalpingiosis	0
fallopian tube endometriosis	0

paths to the root